Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...
The study "Reducing MRI Use in Organised Prostate Cancer Testing Using Blood-Based Biomarkers - the OPT Stockholm3 Study" ...
Sentara invests $1.3M in MRI upgrade at BelleHarbour, promising sharper images, faster prostate scans and expanded capacity ...
A leading hospital in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding advanced cancer ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Aga Khan University Hospital bets in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding ...
(NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 418 owned and/or operated outpatient imaging centers ...
A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.
Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results